Skip to main content
Disha (Kumar) Narang, MD, Endocrinology, Skokie, IL

Disha (Kumar) Narang MD

Diabetes, Lipid Metabolism


Clinical Endocrinologist

Join to View Full Profile
  • 9977 Woods Dr1000 N Westmoreland RdSkokie, IL 60077

  • Phone+1 847-663-8540

Dr. Narang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2011 - 2014
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2011

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2015 - 2026
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • Obesity Medicine
    American Board of Obesity Medicine Obesity Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Racial Differences in TBS
    Kumar D, Vokes T, Costello M, Hans D, Department of Medicine 2015 Janet D. Rowley Research Day, University of Chicago, 3/3/2015
  • Autoimmune Thyroid Disease in Patients with Idiopathic Pulmonary Fibrosis
    Kumar D, Oldham JM, Vij R, Demchuk C, Strek M, Noth I, American Thoracic Society 2014 International Conference, San Diego, CA, 5/18/2014
  • An Unusual Case of Severe Cardiomyopathy and Asthma: Eosinophilic Granulomatosis with Polyangiitis (EGPA)
    Kumar D, Hossain N, Bhorade SM, Resident Research Day, University of Chicago, 5/22/2013
  • Join now to see all

Lectures

  • Racial Differences in TBS 
    University of Chicago - 5/4/2015
  • Addressing Literacy and Numeracy to Prevent Early Childhood Obesity 
    Vanderbilt University, Nashville, TN - 7/30/2008

Press Mentions

  • GLP-1s Come with High Price Tags and Major Side Effects. Could Microdosing Be the Answer?
    GLP-1s Come with High Price Tags and Major Side Effects. Could Microdosing Be the Answer?August 17th, 2025
  • FDA Crackdown on Off-Brand Ozempic Products Set to Take Effect, Threatening Supply and Access for Many
    FDA Crackdown on Off-Brand Ozempic Products Set to Take Effect, Threatening Supply and Access for ManyMay 21st, 2025
  • FDA Halts Sale of off-Brand Ozempic and Other GLP-1 Drugs
    FDA Halts Sale of off-Brand Ozempic and Other GLP-1 DrugsMay 21st, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: